For years, vaccines were considered by many a dull field, characterized by low technology, low margin products. That picture is changing rapidly now. The combined technologies of Pharmexa in Hørsholm and Pharmexa-Epimmune in San Diego allow us to format our vaccines to get exactly the type of immune response we believe will be effective for a particular disease.
Read the feature article
